Chemical Structure (Image 01)
Angeliq Tablet, Film Coated
Product Images NDC 50419-482
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Angeliq (NDC 50419-482). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figuree 1 (Image 02)
0.25mg of Drospirenone and 0.5mg of Estradiol and 0.5mg of Drospirenone and 1mg of Estradiol are mentioned in the text. The graphs seem to be illustrating the levels of Drospirenone and Estradiol in a time frame of 18 and 12 hours respectively. There are no other significant details mentioned in the text to provide any further information.*
Figure 2 (Image 03)
Angeliq 1's Trade (Image 04)
Angeliq 0.25/0.5 mg Carton (Image 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
